Investing.com – Laboratory America reported third-quarter earnings that exceeded analysts’ expectations Thursday and lower-than-expected revenues.
The company reported earnings per share of $ 4.68 on revenue of $ 3.60. Analysts interviewed by Investing.com had expected EPS of $ 4.67 on revenue of $ 3.8 billion.
Since the beginning of the year, Laboratory America shares have fallen 4%, above the performance which has fallen by 19% since the beginning of the year.
Laboratory America follows other health care companies that reported results this month.
On October 14, UnitedHealth announced third-quarter EPS of $ 5.79 on revenue of $ 80.9 billion, compared to the expected EPS of $ 5.43 on revenue of $ 80.52 billion.
J&J results exceeded consensus expectations on Oct. 18, with third-quarter EPS of $ 2.55 on revenue of $ 23.79 billion. Analysts interviewed by Investing.com had expected EPS of $ 2.52 on revenue of $ 23.46 billion
